Injection of Botulinum Toxin A for the Treatment of Dysfunction of the Upper Esophageal Sphincter

2006 ◽  
Vol 2006 ◽  
pp. 168-169
Author(s):  
M.A. Keefe
2005 ◽  
Vol 26 (3) ◽  
pp. 157-162 ◽  
Author(s):  
Thomas Murry ◽  
Tamara Wasserman ◽  
Ricardo L. Carrau ◽  
Beatriz Castillo

2004 ◽  
Vol 18 (6) ◽  
pp. 397-399 ◽  
Author(s):  
Louis WC Liu ◽  
Mark Tarnopolsky ◽  
David Armstrong

Inclusion body myositis (IBM) is a progressive degenerative skeletal muscle disease leading to weakening and atrophy of both proximal and distal muscles. Dysphagia is reported in up to 86% of IBM patients. Surgical cricopharyngeal myotomy may be effective for cricopharyngeal dysphagia and there is one published report that botulinum toxin A, injected into the cricopharyngeus muscle using a hypopharyngoscope under general anesthesia, relieved IBM-associated dysphagia. This report presents the first documentation of botulinum toxin A injection into the upper esophageal sphincter using a flexible esophagogastroduodenoscope under conscious sedation, to reduce upper esophageal sphincter pressure and successfully alleviate oropharyngeal dysphagia in two IBM patients.


2000 ◽  
Vol 110 (7) ◽  
pp. 1151-1156 ◽  
Author(s):  
Jürgen Alberty ◽  
Michael Oelerich ◽  
Karl Ludwig ◽  
Sabine Hartmann ◽  
Wolfgang Stoll

2012 ◽  
Vol 1 (1-2) ◽  
Author(s):  
Heather Fels ◽  
Hindi E. Stohl ◽  
Richard H. Lee ◽  
Paola Aghajanian

AbstractThere is a paucity of data on the perinatal management of achalasia, an esophageal dysmotility disorder involving an abnormal relaxation of the lower esophageal sphincter. Botulinum toxin A is a well-described treatment for achalasia in the non-pregnant state but has been infrequently used for treatment of this condition in pregnancy. We describe a case of a successful treatment of achalasia in the first trimester of pregnancy with botulinum toxin A, and a subsequently uncomplicated pregnancy course and pregnancy outcome.


2015 ◽  
Vol 2015 ◽  
pp. 1-3 ◽  
Author(s):  
Nicole Hooft ◽  
Emily S. Schmidt ◽  
Ross M. Bremner

Background. Achalasia, a rare esophageal motility disorder that may cause malnutrition during pregnancy, can result in fetal and maternal morbidity and mortality. Many medical treatment regimens are contraindicated or not tolerated during pregnancy, and surgery is generally avoided due to potential risks to the fetus.Case Report. Severe, medically refractory achalasia in a 23-year-old pregnant woman that caused malnutrition was successfully managed by administering a botulinum toxin A injection to the lower esophageal sphincter. The injection was performed at approximately 14 weeks’ gestation and the patient reported clinically significant relief from dysphagia. She gained weight and ultimately delivered a healthy baby girl at term, but her symptoms returned a few months postpartum. She underwent a second treatment of botulinum toxin A injection, but it offered only one month of relief. Roughly eight months after delivery, the patient underwent a laparoscopic extended Heller myotomy and Dor fundoplication. The patient resumed a normal diet one week postoperatively, and her baby has had no complications.Conclusion. This is only the second reported case of botulinum toxin A injection being used to treat achalasia in pregnancy. This treatment proved to be a safe temporary alternative without the risks of surgery and anesthesia during pregnancy.


2007 ◽  
Vol 177 (4S) ◽  
pp. 393-393
Author(s):  
Yao-Chi Chuang ◽  
Yao-Chi Chuang ◽  
Dae Kyung Kim ◽  
Po-Hui Chiang ◽  
Michael B. Chancellor

2005 ◽  
Vol 173 (4S) ◽  
pp. 305-305
Author(s):  
Brigitte Schurch ◽  
Marianne de Seze ◽  
Pierre Denys ◽  
Emmanuel Chartier-Kastler ◽  
Francois Haab ◽  
...  

2004 ◽  
Vol 171 (4S) ◽  
pp. 94-94
Author(s):  
Yao-Chi Chuang ◽  
Naoki Yoshimura ◽  
Chao-Cheng Huang ◽  
Po-Hui Chiang ◽  
Michael B. Chancellor

Sign in / Sign up

Export Citation Format

Share Document